Innovent Biologics, Inc. (IVBIY)
OTCMKTS · Delayed Price · Currency is USD
39.75
0.00 (0.00%)
At close: Jan 29, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $19.9 billion as of February 12, 2026. Its market cap has increased by 202.17% in one year.
Market Cap
19.90B
Enterprise Value
19.04B
Revenue
1.59B
Ranking
n/a
PE Ratio
125.89
Stock Price
$39.75
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 19.90B, an increase of 741.74%. That is a compound annual growth rate of 33.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 19.90B | 17.10% |
| Dec 31, 2025 | 16.99B | 120.15% |
| Dec 31, 2024 | 7.72B | -12.83% |
| Dec 29, 2023 | 8.85B | 34.32% |
| Dec 30, 2022 | 6.59B | -27.14% |
| Dec 31, 2021 | 9.05B | -39.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |